ロード中...
Therapy-induced E-cadherin downregulation alters expression of programmed death ligand-1 in lung cancer cells
OBJECTIVES: Immunotherapy that targets the programmed death-1 / programmed death-ligand 1 (PD-L1) axis has been approved for treatment of non-small cell lung cancer (NSCLC) patients in many countries. However, our current understanding of the role of immunotherapies on NSCLC patients with epidermal...
保存先:
| 出版年: | Lung Cancer |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6174882/ https://ncbi.nlm.nih.gov/pubmed/28577937 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lungcan.2017.04.010 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|